In ovarian cancer cells, BRDT shRNA or CRISPR-Cas9-indueced BRDT knockout potently inhibited cell growth, survival, proliferation and migration, whereas inducing apoptosis activation. This evidence concerns the gene BRDT and ovarian cancer.